BioMarin Pharmaceutical | Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
Acadia Pharmaceuticals USD 124.9M 1.24M 2025-09
Agios Pharmaceuticals USD 41.27M 4.6M 2025-09
Alnylam Pharmaceuticals USD 262.59M 60.72M 2025-09
Amgen USD 1.94B 237M 2025-12
Bayer EUR 3.4B 140M 2025-09
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
Gilead Sciences USD 1.78B 425M 2025-12
Incyte USD 390.41M 61.33M 2025-12
Insmed USD 186.38M 109.94M 2025-09
Ionis Pharmaceuticals USD 86.56M 4.04M 2025-09
Moderna USD 268M 38M 2025-09
Neurocrine Biosciences USD 301.8M 10.2M 2025-12
PTC Therapeutics USD 84.05M 1.22M 2025-09
Puma Biotechnology USD 16.82M 8.15M 2024-09
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sanofi EUR 2.75B 455M 2025-12
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
Ultragenyx Pharmaceutical USD 86.62M 26K 2025-09
United Therapeutics USD 152M 60.5M 2025-09
Vertex Pharmaceuticals USD 445.1M 20.5M 2025-09


BioMarin Pharmaceutical Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.